Colorectal cancer (CRC) is the second most commonly diagnosed cancer among females
and third among males worldwide. It also contributes significantly to cancer-related deaths …

Treatments for colorectal cancer (CRC) of all stages have evolved considerably over the
past two decades, resulting in improved long-term outcomes. After curative treatment …

Tumor-infiltrating immune cells (TIICs) play essential roles in cancer development and
progression. However, the association of TIICs with prognosis in colorectal cancer (CRC) …

Biomarkers currently play an important role in the detection and management of patients
with several different types of gastrointestinal cancer, especially colorectal, gastric, gastro …

Nowadays, the development of new technological solutions in the medical field, in particular
biosensors, is a priority and a ground for great scientific and financial investment. From …

The first evidence that screening for colorectal cancer (CRC) could effectively reduce
mortality dates back 20 years. However, actual population screening has, in many countries …

Simple Summary Colorectal cancer (CRC) is one of the most prevalent cancers worldwide.
Due to the absence of specific early symptoms, most of CRC patients are often diagnosed at …

METHODS: Whole stool samples (n= 1,047) were prospectively collected and subjected to
an MT-sDNA test, which tests for KRAS mutations, NDRG4 and BMP3 promoter methylation …

Colorectal cancer (CRC), although a significant cause of morbidity and mortality worldwide,
has seen a declining incidence and mortality in countries with programmatic screening …

Colorectal cancer (CRC) is the third leading cause of cancer‐related deaths worldwide. It
has been estimated that more than one‐third of patients are diagnosed when CRC has …